journal article·2018-11-12Open access

Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells

Hasanain Gomhor J. Alqaraghuli, Soheila Kashanian, Ronak Rafipour, Elahe Mahdavian, Kamran Mansouri

Abstract

Epirubicin (Epr) is an effective chemotherapeutic drug; however, the clinical amenability of Epr is limited by its highly toxic interaction with normal cells. This toxicity can be decreased by utilizing nanocarriers and targeted drug delivery systems. This work describes an approach for the delivery of Epr via encapsulation in the horse spleen apoferritin (HsAFr) cavity. The encapsulation was achieved by the disassembling of apoferritin into subunits at pH 2 followed by its reformation at pH 7.4 in the presence of Epr. The surface of HsAFr-encapsulated Epr was modified with folic acid (FA) for optimal targeting of breast cancer cells (MCF-7). The use of FA to functionalize HsAFr could enhance the cellular uptake efficiency via FA-receptor-mediated endocytosis. UV-vis spectroscopy, fluorescence spectroscopy, circular dichroism (CD) and transmission electron microscopy (TEM) were utilized for structural characterization of the HsAFr-Epr and HsAFr-Epr-FA complexes. The comparison of the anti-cancer activities across the HsAFr-Epr-FA complex and the free Epr drug was performed using the MTT viability assay on MCF-7.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Iron Metabolism and Disorders · Advanced biosensing and bioanalysis techniques · Trace Elements in Health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Applied Chemistry, Faculty of Chemistry, Razi University

Department of General Sciences, College of Basic Education, Al-Muthanna University

Faculty of Chemistry, Sensor and Biosensor Research Center (SBRC) & Nanoscience and Nanotechnology Research Center (NNRC), Razi University

Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences

Department of Chemistry, Kermanshah Branch, Islamic Azad University

Department of Chemistry and Physics, Louisiana State University in Shreveport

Medical Biology Research Center, Kermanshah University of Medical Sciences

References (55)

Show source-provided references
1. 10.3322/caac.2126210.3322/caac.21262 ↗
2. 10.1038/nrc.2016.5410.1038/nrc.2016.54 ↗
3. 10.1039/C6NR07315H10.1039/C6NR07315H ↗
4. 10.1039/C4NR00915K10.1039/C4NR00915K ↗
5. 10.2147/IJN.S13026710.2147/IJN.S130267 ↗
6. 10.1016/j.ijpharm.2016.12.03810.1016/j.ijpharm.2016.12.038 ↗
7. 10.1080/10717544.2018.146408210.1080/10717544.2018.1464082 ↗
8. 10.1002/chem.20170116410.1002/chem.201701164 ↗
9. 10.1021/nl903313r10.1021/nl903313r ↗
10. 10.1016/j.jprot.2012.03.01310.1016/j.jprot.2012.03.013 ↗
11. 10.1021/bm200026v10.1021/bm200026v ↗
12. 10.5599/obp.8.810.5599/obp.8.8 ↗
13. 10.2147/IJN.S10803910.2147/IJN.S108039 ↗
14. 10.1039/c3nr04268e10.1039/c3nr04268e ↗
15. 10.1039/C5CC03180J10.1039/C5CC03180J ↗
16. 10.1016/j.aca.2012.10.04110.1016/j.aca.2012.10.041 ↗
17. 10.1016/j.ejps.2016.10.01110.1016/j.ejps.2016.10.011 ↗
18. 10.1039/C6NR01044J10.1039/C6NR01044J ↗
19. 10.1016/j.pharmthera.2009.10.00210.1016/j.pharmthera.2009.10.002 ↗
20. 10.1007/s10557-016-6711-010.1007/s10557-016-6711-0 ↗
21. 10.1016/j.breast.2011.12.01210.1016/j.breast.2011.12.012 ↗
22. 10.1016/j.jconrel.2015.09.04510.1016/j.jconrel.2015.09.045 ↗
23. 10.1021/acs.molpharmaceut.7b0034110.1021/acs.molpharmaceut.7b00341 ↗
24. 10.1021/acsami.6b0428610.1021/acsami.6b04286 ↗
25. 10.1021/nl104141g10.1021/nl104141g ↗
26. 10.1186/s12885-016-2637-y10.1186/s12885-016-2637-y ↗
27. 10.1016/j.jconrel.2016.09.01010.1016/j.jconrel.2016.09.010 ↗
28. 10.3109/10799893.2016.114758110.3109/10799893.2016.1147581 ↗
29. 10.1007/s10856-017-5859-x10.1007/s10856-017-5859-x ↗
30. 10.1039/C5RA24285A10.1039/C5RA24285A ↗
31. 10.1021/bc060361p10.1021/bc060361p ↗
32. 10.1155/2012/73867810.1155/2012/738678 ↗
33. 10.1007/s11051-014-2293-610.1007/s11051-014-2293-6 ↗
34. 10.1080/03639045.2016.125424010.1080/03639045.2016.1254240 ↗
35. Grigoryan K, Shilajyan H. Fluorescence 2D and 3D spectra analysis of tryptophan, tyrosine and phenylalanine. Chem Biol. 2017;51:3–7.
36. 10.1016/j.jssc.2015.10.01910.1016/j.jssc.2015.10.019 ↗
37. 10.1039/C4TB01336K10.1039/C4TB01336K ↗
38. 10.1007/s11033-012-1742-510.1007/s11033-012-1742-5 ↗
39. Weichel M, Bassarab S, Garidel P. Probing thermal stability of MAbs by intrinsic tryptophan fluorescence. BioProcess Int. 2008;6:42–52.
40. 10.4236/jbpc.2015.6300910.4236/jbpc.2015.63009 ↗
41. 10.1021/jp101096r10.1021/jp101096r ↗
42. 10.1021/ja057069x10.1021/ja057069x ↗
43. 10.1039/c1jm10575b10.1039/c1jm10575b ↗
44. 10.1016/j.foodchem.2013.10.11510.1016/j.foodchem.2013.10.115 ↗
45. 10.1021/nn305791q10.1021/nn305791q ↗
46. Dostalova S, Vazzana M, Vaculovicova M, et al. Interaction of nanocarrier apoferritin with cytotoxic drug molecules. J Metallom Nanotechnol. 2015;3:71–80.
47. 10.1021/ja909475m10.1021/ja909475m ↗
48. 10.1002/cmdc.20170029510.1002/cmdc.201700295 ↗
49. 10.1016/j.colsurfb.2011.11.02910.1016/j.colsurfb.2011.11.029 ↗
50. 10.1002/smll.20170104510.1002/smll.201701045 ↗
51. 10.1002/adhm.20150038910.1002/adhm.201500389 ↗
52. 10.1016/j.jinorgbio.2016.01.01810.1016/j.jinorgbio.2016.01.018 ↗
53. 10.1016/j.bios.2017.12.01110.1016/j.bios.2017.12.011 ↗
54. 10.1002/adfm.20170679310.1002/adfm.201706793 ↗
55. 10.1016/j.ijbiomac.2018.04.14210.1016/j.ijbiomac.2018.04.142 ↗